Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 944Neoplasms 713Prostatic Neoplasms 498Lung Neoplasms 402Colorectal Neoplasms 363Carcinoma, Non-Small-Cell Lung 362Leukemia, Myeloid, Acute 290Pancreatic Neoplasms 239Brain Neoplasms 230Neoplasm Metastasis 225Multiple Myeloma 218Carcinoma, Hepatocellular 202Head and Neck Neoplasms 187Glioblastoma 183Precursor Cell Lymphoblastic Leukemia-Lymphoma 181Melanoma 177Ovarian Neoplasms 170Squamous Cell Carcinoma of Head and Neck 161Rectal Neoplasms 145Uterine Cervical Neoplasms 144Recurrence 143Hematologic Neoplasms 137Sarcoma 136Glioma 132Stomach Neoplasms 129Triple Negative Breast Neoplasms 127Carcinoma, Renal Cell 126Myelodysplastic Syndromes 114Colonic Neoplasms 113Esophageal Neoplasms 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Fibroadenoma × 90 days × Clear all
NCT03868475 2026-03-09

VAPEX

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Withdrawn
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Cicatrix, Phyllodes Tumor, Patient Satisfaction, Fibroadenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡